SynapDx Corporation is joining a select group of autism-focused companies to present at the inaugural Autism Investment Conference, held today in New York, NY and sponsored by Autism Speaks. SynapDx’s CEO Stanley Lapidus will share his vision for addressing the unmet needs in autism diagnosis as part of the panel entitled “Diagnostics and Enabling Technologies.” Lapidus will also update the community on SynapDx’s research efforts to further development of its breakthrough blood-based autism spectrum disorder (ASD) diagnostic test, designed to help clinicians identify children with autism earlier than they do today.